IP Library Assignment 031017/0552
Patent Assignment
Reel/Frame 031017/0552

Assignment of Assignor's Interest

Recorded: 2013-08-15 Pages: 2
Assignors
HAHN, SUNGTACK SAMUEL
Executed: 2003-05-12
RIEHL, PETER R.
Executed: 2003-05-16
Assignee
STELLAR INTERNATIONAL INC.
82 WELLINGTON STREET SOUTH, SUITE 201, LONDON, ONTARIO, N6B 2K3, CANADA
Covered Property (1)
Cystitis Treatment with High Dose Chondroitin Sulfate
Patent: 8,778,908 →
Application: 13/717,551 →
Publication: US 2013/0143839
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Feb 21, 2013
From: STELLAR PHARMACEUTICALS INC.
To: TRIBUTE PHARMACEUTICALS CANADA INC.
Reel/Frame 029849/0376 →
Security Agreement Aug 8, 2013
From: TRIBUTE PHARACEUTICALS CANADA LLC
To: SWK FUNDING LLC
Reel/Frame 030988/0171 →
Merger Aug 15, 2013
From: STELLAR INTERNATIONAL INC.
To: STELLAR PHARMACEUTICALS INC.
Reel/Frame 031017/0766 →
Security Interest Nov 4, 2014
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 034102/0715 →
Release of Security Interest Feb 5, 2016
From: SWK FUNDING LLC
To: TRIBUTE PHARMACEUTICALS CANADA, INC.
Reel/Frame 037674/0301 →
Change of Name Mar 7, 2018
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: ARALEZ PHARMACEUTICALS CANADA INC.
Reel/Frame 045518/0563 →
Security Interest Dec 31, 2018
From: NUVO PHARMACEUTICALS INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY; ARALEZ PHARMACEUTICALS CANADA INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
Reel/Frame 047875/0410 →
Release of Security Interest Mar 14, 2023
From: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
To: NUVO PHARMACEUTICALS INC.; ARALEZ PHARMACEUTICALS CANADA INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY (F/K/A NUVO PHARMACEUTICALS (IRELAND) LIMITED)
Reel/Frame 062974/0236 →